The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2014
DOI: 10.1016/j.breast.2013.11.002
|View full text |Cite
|
Sign up to set email alerts
|

MarginProbe® – Final results of the German post-market study in breast conserving surgery of ductal carcinoma in situ

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
24
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 40 publications
(24 citation statements)
references
References 9 publications
0
24
0
Order By: Relevance
“…Both SR and IOUS guided surgery can be used directly by surgeons within the operating theatre; however neither technique is as accurate as pathological approaches and both are subject to intraobserver error [34]. A common limitation of all emerging technologies such as MarginProbe™ [23, 24], ClearEdge™ [25] or OCT [30] is the need to disrupt workflow demanding an additional probe during resection or specimen analysis following resection. Following excision, the exact orientation of the surgical specimen can prove to be challenging and this may affect accurate margin identification.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Both SR and IOUS guided surgery can be used directly by surgeons within the operating theatre; however neither technique is as accurate as pathological approaches and both are subject to intraobserver error [34]. A common limitation of all emerging technologies such as MarginProbe™ [23, 24], ClearEdge™ [25] or OCT [30] is the need to disrupt workflow demanding an additional probe during resection or specimen analysis following resection. Following excision, the exact orientation of the surgical specimen can prove to be challenging and this may affect accurate margin identification.…”
Section: Discussionmentioning
confidence: 99%
“…A variety of imaging and probe-based devices are emerging that are designed to detect differences in tissue properties between cancerous and normal breast tissue [22]. Bioimpedance is the measure of the response of tissue to an externally applied electrical current; the MarginProbe™ is quick (~5–7 minutes) and a 50% reduction in re-operation rates is achievable despite modest sensitivity and specificity (~70%) [23, 24]. Similarly, the ClearEdge™ system measures tissue-specific electrical properties with promising preliminary data (sensitivity ~85%, specificity ~80%) [25].…”
Section: Introductionmentioning
confidence: 99%
“…On the downside, limited sensitivity, specificity, field of view, and penetration imply that complete margin assessment is neither practical nor possible, leading to a possibility of missed malignant tissue within the margin. 12 Intraoperative ultrasound (US) examination is a convenient, nondestructive method with reported high specificity; however, it remains unable to overcome sensitivity problems in younger and denser breasts especially with high-grade tumors exhibiting intraductal components. 13,14 Alternatively, recent studies using optical techniques, such as Raman spectroscopy, autofluorescence spectroscopy, optical coherence tomography, and diffuse reflectance spectroscopy have demonstrated superior soft tissue contrast, resulting in margin assessment sensitivity as high as 100% and specificity of nearly 92%.…”
Section: Overviewmentioning
confidence: 99%
“…Optical coherence tomography demonstrated higher scattering tissue with a heterogeneous pattern is a marker of tumor cells and tumor tissue relative to normal breast tissue, and found in a small case series a very encouraging sensitivity of 100% and specificity of 82% . A novel handheld device, the MarginProbe (Dune Medical Devices, Caesarea, Israel), has demonstrated high sensitivity (97% for tumors greater than 0.7 mm) and specificity (87% on relatively homogeneous sites) . This device has also been shown to reduce re‐excisons in patient with DCIS by more than 50% .…”
Section: Improving Intraoperative Assesement Of Marginsmentioning
confidence: 99%